Azaadamantane derivatives and their uses as nicotinic acetylcholine receptors ligands

Details for Australian Patent Application No. 2007316480 (hide)

Owner Abbott Laboratories

Inventors Sippy, Kevin B.; Shi, Lei; Zhang, Geoff G.Z.; Scanio, Marc; Nersesian, Diana L.; Chen, Shuang; Lee, Chih-Hung; Brackemeyer, Paul J.; Li, Tao; Henry, Rodger F.; Bunnelle, Willaim H.; Ji, Jianguo; Schrimpf, Michael R.

Agent Spruson & Ferguson

Pub. Number AU-B-2007316480

PCT Pub. Number WO2008/058096

Priority 60/908,143 26.03.07 US; 11/935,157 05.11.07 US; 60/856,992 06.11.06 US

Filing date 6 November 2007

Wipo publication date 15 May 2008

Acceptance publication date 16 August 2012

International Classifications

C07D 451/14 Heterocyclic compounds containing condensed hetero ring systems

A61K 31/395 - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

Event Publications

14 May 2009 PCT application entered the National Phase

  PCT publication WO2008/058096 Priority application(s): WO2008/058096

11 June 2009 Amendment Made

  The nature of the amendment is: Amend the priority details to read from US 11/935,257 5 November 2007 to US 11/935,157 5 November 2007

16 August 2012 Application Accepted

  Published as AU-B-2007316480

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007316482-Method of treating asthma, allergic rhinitis, and skin disorders

2007316477-Content management system